Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Associate

Organic Chemistry · South Korea · 2022-09-29

Processing Time
174 days
Decision Date
2022-09-29
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue identifying lead molecules to develop novel drugs for treating cancer, autoimmune diseases, addiction, neurodegenerative diseases, and viral infections. The work specifically focuses on translesion synthesis to support the development of targeted therapeutics that circumvent drug resistance in cancer patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor has national importance due to its role in facilitating cancer therapeutics and aiding the country's ongoing opioid epidemic.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned through 14 years of experience and a significant publication record of 22 peer-reviewed articles with 412 citations.

3 Balance of Factors to Waive Job Offer Met

The petitioner's superior experience and the critical nature of the research for U.S. health initiatives justified the waiver.

Why This Petition Was Approved

The petition was approved based on the petitioner's 14 years of research experience and a record of 22 peer-reviewed journal articles which accumulated 412 citations. The work's national importance was further validated by funding from the National Institutes of Health (NIH), National Cancer Institute (NCI), and the National Institute of Allergy and Infectious Diseases (NIAID).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.
View Case

Scientist

Pharmaceuticals · New Zealand

WeGreened EB-2 (NIW) approved
California 467 days 2025-03-05
The petitioner proposes to design and optimize novel small-molecule therapeutics to improve cancer patient outcomes, specifically targeting difficult-to-treat cancers. Their work involves leveraging synthetic organic chemistry and catalysis to develop innovative approaches for constructing biologically active lead compounds with enhanced pharmacological profiles.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Indiana 296 days 2025-02-24
The petitioner proposes to develop targeted cancer therapeutics and precision-based therapeutic options to prevent the recurrence of malignant diseases. The work focuses on creating cost-effective, personalized, and immunological therapies to simplify cancer diagnosis and treatment. The endeavor aims to improve treatment outcomes, reduce side effects, and lower long-term healthcare costs in the United States.
View Case

Scientist

Research and Development · Hong Kong

WeGreened EB-2 (NIW) approved
Massachusetts 80 days 2022-04-23
The petitioner proposes to continue research on developing and improving oncology and neurology drugs and treatment methods. The work focuses on validating new therapeutic targets and developing molecular treatments for prominent diseases, including cancer, to improve global public health outcomes.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from South Korea

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-09-29.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 174 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in South Korea All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist